Skip to Content
🌐Ship toSelect country

Belotero Soft Lidocaine - 1 x 1,0ml

Belotero Soft is the lightest-density product in the Merz Aesthetics Belotero range (around 20 mg/ml HA), built on CPM cross-linking technology and containing lidocaine. It is designed for very fine superficial lines — such as crow's feet, perioral lines and forehead wrinkles — and is injected into the upper dermis for gentle, seamless integration suited to delicate or thinner skin. For use by licensed, trained medical professionals only.

69.95 € 69.95 €
  • Brand
Terms and Conditions

Shipping: 
DHL EXPRESS SHIPPING (EU) — approx. 2-3 working days
STANDARD SHIPPING (EU) — approx. 7-10 working days
Select your delivery country in the header to check availability for your destination.
Category Fillers Brand BELOTERO®
SKU A0608 Share
Treatment Areas Crow's FeetFaceForeheadNeckPerioral folds
Tags Fine LinesHydrationLidocaine

Belotero Soft is the lightest-viscosity formulation in Merz Aesthetics' CPM hyaluronic acid range, designed for fine superficial lines in delicate areas such as around the eyes and mouth. Its soft, cohesive gel integrates smoothly into thin skin without the lumping or Tyndall effect risk of firmer fillers used in these areas.

Formulated with lidocaine for a more comfortable injection experience.

CONCENTRATION

  • Cross-linked hyaluronic acid (CPM technology), 20mg/g
  • Lidocaine hydrochloride 0.3%

THE PACK INCLUDES

  • 1 x 1.0ml Syringe

STORAGE CONDITIONS

  • Store between 2°C and 25°C
  • Protect from direct sunlight
  • Do not freeze

RESULTS & DURATION

Results typically last 4-6 months, depending on individual metabolism and treatment area.

INDICATIONS

  • Fine superficial lines
  • Crow's feet
  • Perioral lines

TREATMENT AREAS

  • Crow's feet
  • Perioral folds
  • Face, general

Belotero Soft is injected into the superficial dermis using fine linear threading, suited to delicate facial areas.

Results are visible immediately, with final results assessed after 1-2 weeks.

  • Pregnancy or breastfeeding
  • People under the age of 18
  • Active infection or inflammation at the treatment site
  • Known hypersensitivity to hyaluronic acid or lidocaine
  • Patients prone to hypertrophic scarring
  • Autoimmune diseases affecting the skin